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Abstract
Background: Traumatic brain injury (TBI) causes brain dysfunction in many patients. Using C-11 flumazenil (FMZ)
positron emission tomography (PET), we have detected and reported the loss of neuronal integrity, leading to brain
dysfunction in TBI patients. Similarly to FMZ PET, I-123 iomazenil (IMZ) single photon emission computed tomography
(SPECT) is widely used to determine the distribution of the benzodiazepine receptor (BZR) in the brain cortex. The
purpose of this study is to examine whether IMZ SPECT is as useful as FMZ PET for evaluating the loss of neuronal
integrity in TBI patients.
The subjects of this study were seven patients who suffered from neurobehavioral disability. They underwent IMZ SPECT
and FMZ PET. Nondisplaceable binding potential (BPND) was calculated from FMZ PET images. The uptake of IMZ was
evaluated on the basis of lesion-to-pons ratio (LPR). The locations of low uptake levels were visually evaluated both in IMZ
SPECT and FMZ PET images. We compared FMZ BPND and (LPR-1) of IMZ SPECT.
Results: In the visual assessment, FMZ BPND decreased in 11 regions. In IMZ SPECT, low uptake levels were observed in
eight of the 11 regions. The rate of concordance between FMZ PET and IMZ SPECT was 72.7%. The mean values IMZ
(LPR-1) (1.95 ± 1.01) was significantly lower than that of FMZ BPND (2.95 ± 0.80 mL/mL). There was good correlation
between FMZ BPND and IMZ (LPR-1) (r = 0.80).
Conclusions: IMZ SPECT findings were almost the same as FMZ PET findings in TBI patients. The results indicated that
IMZ SPECT is useful for evaluating the loss of neuronal integrity. Because IMZ SPECT can be performed in various facilities,
IMZ SPECT may become widely adopted for evaluating the loss of neuronal integrity.
Background
Traumatic brain injury (TBI) causes brain dysfunction in
many patients. Patients with head injury who do not show
residual focal neurological symptoms, such as paralysis
and aphasia, are often discharged to return home after the
acute phase, without confirmation of the need for rehabili-
tation. However, even patients who had suffered a mild
head injury may experience after-effects including fatigue,
memory disorder, and poor concentration, which
significantly and adversely affect their daily life [1–3].
Neurobehavioral disability such as impaired attention,
memory disorder, and executive function disorder will
interfere with patients’ education and employment oppor-
tunities, causing serious economic losses and significant
decrease in the quality of their daily life. Therefore, it is
important to promptly make an accurate diagnosis, under-
stand the clinical conditions, and provide rehabilitation
and support to patients on the basis of such a diagnosis.
Because many of neurobehavioral disability caused by
TBI cannot be explained only by the site of the brain in-
jury detected by magnetic resonance imaging (MRI), it is
difficult to diagnose neurobehavioral disability caused by
TBI in many patients. The visualization of the lesions re-
sponsible for neurobehavioral disability is essential for
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understanding the clinical conditions, making a diagno-
sis, and providing appropriate rehabilitation.
Several reports have shown that the loss of neuronal
integrity could be detected using C-11 flumazenil (FMZ)
positron emission tomography (PET) [4–9]. We also
have reported that TBI patients had low FMZ nondis-
placeable binding potential (BPND) lesions indicating loss
of neuronal integrity without MRI findings [4].
Similarly to FMZ PET, I-123 iomazenil (IMZ) single
photon emission computed tomography (SPECT) can
also be used to determine the distribution of the benzo-
diazepine receptor (BZR). IMZ SPECT has already been
used clinically in many facilities for detecting epileptic
foci in epilepsy patients.
Although IMZ is expected to show results similar to
FMZ, IMZ is a SPECT tracer and FMZ is a PET tracer.
Moreover, whereas the quantification method for FMZ
PET has been established, quantification by IMZ SPECT
is difficult and requires considerable efforts, thus limit-
ing its use. To the best of our knowledge, there have
been no studies in which FMZ PET findings and IMZ
SPECT findings were compared in TBI patients, nor
studies on whether those findings agree with each other.
The purpose of this study is to examine whether IMZ
SPECT is as useful as FMZ PET for evaluating the loss




The subjects of this study were seven patients who suf-
fered from neurobehavioral disability after TBI. The pa-
tients underwent FMZ PET, IMZ SPECT, and MRI.
Patient characteristics were shown in Table 1. TBI oc-
curred at least 2 months (mean, 6 ± 5.6 months) previ-
ous to the time of FMZ PET and at least 6 months
(mean, 17.7 ± 12.6 months) previous to the time of IMZ
SPECT. The mean age of the patients was 30.3 years
(standard deviation, 11.6 years). Of the seven patients,
five were males and two were females. The causes of
injury were traffic accident in five patients, assault in
one patient, and sport-related in one patient. Epilepsy
patients were not included in this study.
Ethics, consent, and permissions
The volunteers gave their written, informed consent in
accordance with the Helsinki II declaration, and this
study was approved by the Ethics Committees of
Hokkaido University Graduate School of Medicine.
PET
Images were acquired with a 5-min transmission scan
and a 60-min dynamic emission scan with the HR+ PET
scanner (Asahi-Siemens, Tokyo, Japan) in the 3D acqui-
sition mode, and images were reconstructed with the
brain mode of manufacturer’s software. The energy win-
dow was 350–650 keV. The acquired 3D sinograms were
converted into 2D sinograms with the Fourier rebinning
algorithm. The images were reconstructed by direct-
inversion Fourier transformation. The reconstruction
filter was a Hanning filter with 4-mm FWHM. The re-
construction matrix was 256 × 256, and the FOV was
33 cm in diameter. The full width at half-maximum
(FWHM) was 6.4 mm after reconstruction. FMZ PET
procedures were the same as previously described [6].
Dynamic FMZ PET was performed on all the patients.
The drugs that affect BZR were withdrawn at least
1 week before FMZ PET studies. The injected dose of
FMZ was 370 MBq for each patient. A set of 27 sequen-
tial PET frames of increasing duration were obtained
over 60 min after FMZ injection, according to the fol-
lowing protocol: 40 s × 1 frame, 20 s × 10 frames, 60 s ×
4 frames, 180 s × 4 frames, and 300 s × 8 frames. A refer-
ence tissue compartment model was used for a noninva-
sive estimation of BPND with a time-activity curve in the
pons as an indirect input function (Fig. 1).





Sex WAIS-R, WAIS-III, WISC-III RBMT Diagnosis at the time
of the accident
Period after injury (month) Main symptoms
FIQ VIQ PIQ FMZ IMZ
1 28 M 98 105 90 21 No definite abnormalities 10 10 Irritability, poor concentration
2 51 M 100 99 100 20 Cerebral contusion 17 32 Difficulty of calculation
3 39 M 104 111 94 16 No definite abnormalities 4 10 Memory disorder
4 16 M 75 92 66 22 No definite abnormalities 2 13 Memory disorder
5 21 M 90 98 105 17 Cerebral contusion 2 6 Mental fatigue
6 28 F 85 84 90 23 Traumatic SAH, DAI,
contusion
4 39 Memory disorder
7 29 F 106 101 101 22 ASDH 3 14 Mental fatigue
M male, F female, WAIS-R Wechsler Adult Intelligence Scale-Revised, WAIS-III Wechsler Adult Intelligence Scale-III, WISC-III Wechsler Intelligence Scale for Children-III,
FIQ full intelligence quotient, VIQ verbal intelligence quotient, PIQ performance intelligence quotient, RBMT Rivermead Behavioral Memory Test, SAH subarachnoid
hemorrhage, DAI diffuse axonal injury, ASDH acute subdural hematoma, FMZ C-11 flumazenil, IMZ I-123 iomazenil
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dCf=dt ¼ K 1Cp‐ k2Cf ‐ k3Cf þ k4Cb ð1Þ
dCb=dt ¼ k3Cf ‐ k4Cb ð2Þ
dCr=dt ¼ K10Cp‐ k20Cr ð3Þ
K1
0=k20 ¼ K 1=k2 ð4Þ
BPND ¼ k3=k4 ð5Þ
Cp is the metabolite-corrected plasma concentration
(kBq/mL), Cr is the concentration in reference tissue
(kBq/mL), Cf is the concentration of free (i.e., not specif-
ically bound) ligand (kBq/mL), Cb is the concentration
of specifically bound ligand (kBq/mL), K1 is the rate
constant for transfer from the plasma to free compart-
ment (mL/g/min), k2 is the rate constant for transfer
from the free to the plasma compartment (/min), k3 is
the rate constant for transfer from the free to the bound
component (/min), k4 is the rate constant for transfer
from the bound to the free compartment (/min), K1′ is
the rate constant for transfer from the plasma to the ref-
erence compartment (mL/g/min), k2′ is the rate con-
stant for transfer from the reference to the plasma
compartment (/min), and t is time (min). The oper-
ational equation can be further simplified by assuming
that the volume of distribution of the nonspecifically
bound tracer in both tissues is the same as that obtained
using Eq. (4). Finally, BPND was estimated by the nonlin-
ear least method using Lammertsma’s simplified refer-
ence tissue model [10]. The parametric images were
calculated with the program developed in our institute
using Microsoft Visual C++ 6.0 for Windows.
SPECT
The dose of iodine-123 IMZ was 167 MBq. SPET data
were acquired from 20 to 40 min and 120 to 140 min
after the tracer injection, using a triple-head gamma
camera (GCA-9300/DI, TOSHIBA, Tokyo, Japan)
equipped with low-energy high-resolution fan-beam
collimators. The latter images were used for analysis be-
cause delayed IMZ SPECT activity and distribution vol-
ume of IMZ SPECT had high linear correlation [11].
The energy settings were 160 keV peak with 24% width.
The matrix size was 128 × 128 pixels. The images were
reconstructed using the filtered back-projection method
without scatter correction. The data were pre-processed
using a Butterworth filter with a cutoff frequency of
0.10 cycles per pixel and a power factor of eight. Attenu-
ation correction was performed using Chang’s method.
The attenuation coefficient was set at 0.10/cm. These at-
tenuation coefficient values were determined by a phan-
tom study. The imaging resolution was about 10 mm
full width at half-maximum (FWHM) after reconstruc-
tion. Table 2 shows image acquisition and correction
methods of FMZ PET and IMZ PECT study.
MRI
MRI scan was performed using a 1.5 Tesla scanner
(Magnetome Vision or Magnetome Symphony, Asahi-
Siemens, Tokyo, Japan). Transaxial T2 and T2*
weighted images and FLAIR images were acquired.
All images were acquired with 5-mm slice thickness
and no slice gap. Coronal and sagital images were
added in some cases.
Data analysis
The images obtained were assessed visually and semi-
quantitatively. As described previously, FMZ PET and
delayed IMZ SPECT images were automatically super-
imposed on MRI images using multimodality image
registration techniques [12].
The locations of low-uptake-level regions on FMZ
PET and delayed IMZ SPECT images were visually
assessed in three directions. Two specialists in nuclear
medicine interpreted the images independently. When
their findings did not agree, the presence or absence of
low-uptake-level regions was determined by discussion.
A region of interest (ROI) was placed in the lesions,
which was visually detected on FMZ PET images. The
ROI was circle shaped of 9 mm in diameter. In delayed
IMZ SPECT, a same ROI was placed in the lesion de-
tected in FMZ BPND, and the uptake of IMZ in the ROI
was evaluated. The uptake of delayed IMZ was evaluated
on the basis of lesion-to-pons ratio (LPR), which was
corrected using the pons as the reference region. LPR
corresponded to distribution volume ratio (DVR) of
IMZ because delayed IMZ SPECT activity and distribu-
tion volume of IMZ SPECT had high linear correlation
[11]. BPND is equal to the DVR minus a value of 1, as
described by Innis et al. [13, 14]. We compared FMZ
BPND and (LPR-1) of delayed IMZ SPECT (Fig. 2). The
significant difference was determined by the paired t test
and Pearson’s correlation coefficient to examine the
Fig. 1 Reference tissue model, with a two-tissue compartment model
for the target region and a single-tissue compartment model for the
reference region
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relationship between these two parameters. A difference
of p < 0.05 was determined as significant.
Results
Table 1 shows the diagnosis given at the time of injury,
the period after injury, the main symptoms, the scores
on the Wechsler Adult Intelligence Scale (WAIS)-R [15],
WAIS-III [16], or the Wechsler Intelligence Scale for
Children (WISC)-III [17], and the results of the River-
mead Behavioral Memory Test (RBMT). None of the pa-
tients showed clear focal neurological dysfunction. The
WAIS scores were at or below the cutoff point in two
patients. Two patients had scores at or below the cutoff
point in RBMT. The main symptoms were memory dis-
order in three patients, mental fatigue in two patients,
difficulty of calculation and irritability in one patient,
and irritability in one patient.
A decrease in FMZ BPND was visually detected in 11
regions. In delayed IMZ SPECT images, low uptakes
were observed in nine lesions, eight of which also
showed decreases in FMZ BPND. The rate of concord-
ance between FMZ PET and delayed IMZ SPECT was
72.7%. One lesion not detected by FMZ PET was de-
tected by delayed IMZ SPECT (Table 3). Representative
cases are shown in Figs. 3, 4, and 5.
The (LPR-1) of IMZ SPECT in the 11 lesions which
were detected with FMZ PET was significantly lower
than FMZ BPND (Fig. 6). There was significant correl-
ation between FMZ BPND and IMZ (LPR-1) (p = 0.003).
The correlation coefficient (r) between FMZ BPND and
IMZ (LPR-1) was 0.80, indicating a strong positive cor-
relation between the two (Fig. 7).
Discussion
When FMZ BPND image was used as the reference, eight
of 11 lesions were detected by IMZ SPECT. That is,
most of the lesions were detected by IMZ SPECT. The
sensitivity of FMZ PET in detecting lesions was slightly
Table 2 Image acquisition and correction methods of FMZ PET and IMZ PECT study
FMZ PET study IMZ SPECT study
Tracers C-11 flumazenil I-123 iomazenil
Acquisition system BGO PET system (Asahi-Siemens ECAT EXACT HR+) Triple-head gamma camera with low-energy
high-resolution fan-beam collimators
(Toshiba GCA-9300)
Scatter correction Single scatter simulation method No scattter correction
Attenuation correction Measured with transmission scan Chang’s method
Reconstruction method Fourier rebinning algorithm + direct-inversion Fourier
transformation
Filtered back projection
Image acquisition 60-min dynamic acquisition with 3D mode Static image (20 to 40 min and 120 to 140 min
after the tracer injection)
FWHM (mm) after reconstruction 6.4 10
Fig. 2 Parametric images of FMZ PET and IMZ SPECT. Left is FMZ BPND (0–6.0 mL/mL). Center image is IMZ (LPR-1) ranging from 0 to 5.0. Right
image is IMZ (LPR-1) ranging from 0 to 6.0
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higher than that of IMZ SPECT. However, a lesion that
was not detected by FMZ PET was detected by IMZ
SPECT. IMZ (LPR-1) correlated with FMZ BPND but
was significantly lower than FMZ BPND.
In this study, FMZ PET and IMZ SPECT were used to
identify the loss of neuronal integrity. Both FMZ and
IMZ are tracers that specifically bind to central BZR.
Central BZR forms a complex with the γ-aminobutyric
acid type A (GABAA) receptor and is distributed
throughout the brain cortex.
It has been reported that a low IMZ uptake level cor-
relates with decreased neuronal density in epilepsy pa-
tients [7, 9]; and IMZ has already been used for epilepsy
diagnosis in clinical practice.
Table 3 Findings in the seven patients with respect to location of low FMZ BP and location of low uptake levels on IMZ images
Patient No. MRI Location of low uptake on
FMZ images
Location of low uptake on
IMZ images
1 DAI (microbleeds) Rt parietal lobe Lt temporal lobe Rt medial temporal lobe Rt medial temporal lobe
2 Contusion Rt temporal tip Bilateral frontal lobes Rt medial temporal lobe
Lt frontal tip
Rt medial temporal lobe
3 None Lt basal-medial temporal lobe Lt medial temporal lobe
4 DAI (microbleeds): Lt frontal lobe
Lt parietal lobe
Bilateral cerebella
Rt medial temporal lobe
Lt frontal tip
Rt basal-medial temporal lobe
5 DAI (microbleeds) Bilateral frontal lobes
Bilateral temporal lobes
Lt frontoparietal lobe Lt frontoparietal lobe
Rt basal-medial temporal lobe
6 DAI (microbleeds) Bilateral frontal lobes
Bilateral internal capsules
Bilateral corpus callosa
Rt basal-medial temporal lobe Rt basal-medial temporal lobe
7 DAI (microbleeds) Lt frontal lobe
Lt temporal lobe
Lt brain stem
Rt basala temporal lobe
Lt frontal tip
Lt frontoparietal lobe
Rt basal-medial temporal lobe
Lt frontal tip
MRI magnetic resonance imaging, DAI diffuse axonal injury, Rt right, Lt left, FMZ C-11 flumazenil, IMZ I-123 iomazenil
Fig. 3 Case 1 (Patient No. 1): The patient was a 28-year-old male who
was injured in a car accident 1 year previously. No abnormalities were
found at the time of injury but he complained of irritability and poor
concentration after the injury. Microbleeds in the right parietal lobe
and left temporal lobe were observed on MRI images in the chronic
phase. FMZ BP was low inside the right temporal lobe. The low uptake
level inside the right temporal lobe was also observed by IMZ SPECT
Fig. 4 Case 2 (Patient No. 7): The patient was a 29-year-old female
who was diagnosed as having acute subdural hemorrhage at the time
of injury and complained of mental fatigue and headache after the
injury. FMZ BPND was low inside the left frontal lobe. The low uptake
level inside the left frontal lobe was also observed by IMZ SPECT
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In patients with ischemic cerebrovascular disorder,
FMZ has been reported to be a useful marker indicat-
ing the presence of irreversible changes in neurons,
even in a region where abnormalities were not found
by MRI [6, 8].
Several reports have shown that the loss of neuronal
integrity in TBI patients can be evaluated by FMZ PET
[4, 5]. We have reported that even in patients with head
injury showing no abnormal MRI findings, regions with
a decreased cerebral metabolic rate of oxygen (CMRO2)
were identified by 15O-labeled gas PET, and that a de-
crease in BPND was observed on FMZ PET images in
some of those regions. The decrease in FMZ BPND may
be related to the loss of neuronal integrity, and it
seemed that the decrease in CMRO2 in the regions
showing no loss of neuronal integrity was due to func-
tional hypometabolism [4]. Moreover, in the FMZ PET
of patients with diffuse axonal injury (DAI), abnormal-
ities were observed in regions showing no abnormal
MRI findings [5].
FMZ PET and IMZ SPECT are considered to be useful
for identifying the loss of neuronal integrity. However, a
comparison between FMZ PET and IMZ SPECT in epi-
lepsy patients showed that FMZ PET more accurately
detects epileptic foci, whereas the accuracy of IMZ
SPECT was lower [18]. There has been no report that
FMZ PET findings and IMZ SPECT findings agree with
each other in TBI patients. In this study, most of the
IMZ SPECT findings agreed with the FMZ PET findings,
suggesting that IMZ SPECT was as useful as FMZ PET
for evaluating the loss of neuronal integrity in TBI
patients. However, it should be noted that the IMZ
SPECT and FMZ PET findings were not completely
identical because of the inherent differences between
the tracers (FMZ and IMZ) and image generation
methods; PET v.s. SPECT.
Inherent differences between PET and SPECT and their
tracers
The direction of gamma rays is determined by a collima-
tor in SPECT. PET can determine photon origin using
coincidence detection, it does not require a collimator.
A collimator attenuates large number of incoming radi-
ation; therefore, PET has an increase in sensitivity of two
to three orders of magnitude compared to PET. PET has
excellent performance in resolution and sensitivity [19].
Moreover, PET is superior to SPECT in quantitative per-
formance because absorption is directly measured in
PET, or calculated by CT in PET/CT, whereas that in
SPECT is only corrected using a mathematical model
(Chang’s method). FMZ PET, which has a high spatial
resolution, is more accurate than IMZ SPECT because
abnormalities are determined on the basis of the visual
assessment of low-uptake-level regions. To address the
Fig. 5 Case 3 (Patient No. 5): The patient was a 21-year-old male who
was diagnosed as having right frontal brain contusion at the time of
injury and complained of mental fatigue after the injury. The uptake
level of IMZ SPECT was low at the right basal-medial temporal lobe.
But the low BPND was not observed by FMZ PET
Fig. 6 The (LPR-1) of IMZ SPECT in the 11 lesions which were detected
with FMZ PET was significantly lower than FMZ BPND
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issue of spatial resolution, a high sensitivity SPECT sys-
tem was used in this study. This may be the reason why
the accuracy of IMZ SPECT in this study was higher
than that of the report on the comparison of FMZ PET
and IMZ SPECT in epilepsy patients [18].
FMZ is an antagonist of BZR [20]. In the brain, 80–
90% of FMZ specifically binds to BZR and the rest exists
as free or nonspecifically bound FMZ [21–23]. More-
over, the quantification method for FMZ PET has been
established. FMZ is taken up by the brain immediately
after its injection and is then promptly washed out.
Quantitative values can be obtained by 1-h dynamic
scanning immediately after the injection of FMZ. IMZ is
a partial inverse agonist. The BZR affinity of IMZ is 10-
fold that of FMZ, and the specific-to-nonspecific binding
ratios are 40–50:1 [24, 25]. The quantification method
for IMZ SPECT has not been established. FMZ PET
BPND images are quantitative images that can exclude
nonspecific accumulation. On the other hand, IMZ
SPECT images are qualitative images that cannot ex-
clude nonspecific accumulation, leading to decreased
contrast and decreased sensitivity for detecting abnor-
malities. In contrast, IMZ is an agonist, unlike FMZ,
having pharmacological effects. IMZ is designed as a
tracer that has low ligand occupation rate because of
pharmacological effect.
The accumulation of LPR in IMZ SPECT was deter-
mined in this study. The reference tissue for FMZ BPND
is the pons, which shows little specific accumulation of
BZR. Therefore, the accumulation LPR as determined by
IMZ SPECT was compared with the quantitative value
obtained by FMZ PET. This may be the reason why the
semiquantitative accuracy of IMZ SPECT was improved
and the IMZ (LPR-1) showed a high level of correlation
with FMZ BPND.
Decrease in expression level of BZR
There are three possible causes of a decrease in BZR ex-
pression level. The first is direct injury. Brain contusion
is often located at the bottom, outer surface, and inner
surface of the frontal and temporal lobes, or in the tem-
poral pole [26]. In this study, all the regions showing a
decrease in BZR expression level were located in the
frontal and temporal lobes, with most of them located at
the bottom, inside, and in the pole of these lobes. The
injuries seemed to have been caused by the bone of the
skull base.
The second is DAI. DAI is an axonal injury due to the
shear or distortion induced by rotational acceleration
and is often located at the corticomedullary junction or
in deep white matter [27, 28]. It has been reported that
an axonal injury slowly leads to Wallerian degeneration
and results in delayed neuronal death [29]. Although
BZR is not suitable for detecting disorders in the
white matter because it exists in the gray matter, the
abnormalities detected may indicate neuronal death
caused by DAI. In this study, five patients had DAI
identified by MRI.
The third is apoptosis. Apoptosis was observed in the
injured brain cortex and white matter in a study using
mild TBI models, indicating that TBI was a cause of cell
death [30].
Fig. 7 A positive correlation was found by Pearson’s correlation coefficient between the BPND in the lesions detected by FMZ PET and the (LPR-1)
in the same regions obtained in IMZ SPECT (r2 = 0.638)
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In this study, there was a region where abnormal-
ities were detected only by IMZ SPECT. Such abnor-
malities may be a false positive resulting from the
limited resolution of SPECT and the issues of accur-
acy of the test method such as the lack of quantifica-
tion. Moreover, the results may be affected by the
difference in the time point at which FMZ PET and
IMZ SPECT were carried out.
In this study, IMZ SPECT was carried out several
months after FMZ PET. Therefore, there was a possibility
that secondary changes due to TBI, including Wallerian
degeneration and apoptosis, led to the decrease in BZR
expression level, and, as a result, the abnormalities not de-
tected by FMZ PET were detected by IMZ SPECT.
Further research is required to clarify the temporal
changes detected by IMZ SPECT.
Correlation of FMZ BPND and (LNR-1) of IMZ
We compared FMZ BPND and (LPR-1) of delayed IMZ
SPECT. In previous study, BPND of IMZ SPECT were
much higher than (LPR-1). If IMZ binds about 10 times
as strong as FMZ, (LPR-1) will be 10 times larger than
BPND of FMZ. Millet et.al reported that BPND of IMZ
was about 5 times that of FMZ. Considering that the
spatial resolution of SPECT is worse than that of PET,
BPND of IMZ is considered to be higher than that of
FMZ by more than 5 times. One reason was considered
to be derived from scatter correction. We did not cor-
rect the scatter in SPECT study. This SPECT system is
equipped with Triple energy windows (TEW) scatter
correction. Because the TEW method was reported to
increase the noise [31] and visual interpretation was dif-
ficult in some cases, we decided to analyze SPECT im-
ages without scatter correction. Scatter correction is
important in the quantitative analysis of brain SPECT.
Skull base has high attenuation [32] and therefore gener-
ates a lot of scatter photons. Axelsson et al. [33] re-
ported that the relation between true and measured
concentration ratios was almost linear after scatter cor-
rection and the effect of scatter correction was larger in
the low counts area than in the high counts area. The
activity of pons might be overestimated in this study.
Other reason was derived from static data acquisition.
We did not perform dynamic study in SPECT. Dynamic
study was necessary to calculate accurate DV and BP in
both PET and SPECT study. Other reason was derived
from attenuation correction. Absorption correction of
PET is based on mu map directly measured in PET, or
calculated by CT in PET/CT, and it was more accurate
than that of SPECT system.
Clinical significance of IMZ SPECT
Cerebral blood flow SPECT is more sensitive to TBI-
associated dysfunction than MRI and computed
tomography (CT) [34, 35]. However, blood flow and
glucose metabolism change in connection with the activ-
ities of the patient examined and therefore reflect even a
functional decline that is not due to a neuronal abnormal-
ity. The neuron loss can be more accurately detected
using BZR-specific ligands.
It is considered that FMZ PET has higher diagnostic
accuracy than IMZ SPECT. However, 11C-FMZ must be
purified in a hospital because its half-life is as short as
20 min. It can be used only for research purposes and is
difficult to use in clinical settings. On the other hand,
IMZ has long radioactive half-life, it is easy to handle it.
And it can be used in many facilities because it is more
easily available than FMZ.
Because IMZ SPECT is superior to FMZ PET in terms
of versatility, it is preferable to use IMZ SPECT instead
of FMZ PET to detect the loss of neuronal integrity.
The detection of the loss of neuronal integrity using
IMZ SPECT enables the evaluation of the distribution of
lesions that cannot be observed by MRI. IMZ SPECT
will contribute to the understanding of the cause of neu-
robehavioral disability in patients with head injury but
showing no abnormalities on MRI images. The clinical
symptoms can be better understood when the site of
lesions is identified, leading to the improvement of
insights into the disease and the promotion of the
understanding of affected patients by their families and
surrounding persons. Moreover, although presently the
treatment of neurobehavioral disability mainly involves
supportive care, such as the development of compensa-
tory approach through rehabilitation, the identification
of the site of lesions will lead to a curative treatment
with the development of regenerative medicine in the
future.
Limitations
The number of patients involved in this study was small.
Further research with a larger number of patients is
required in the future.
As for PET system, we used Siemens HR+ PET system
for FMZ PET study. HR+ PET system was a high spatial
resolution BGO PET system (4.39 mm@1 cm in transax-
ial: NEMA NU-2001) and with relatively high sensitivity
(6.65kps/MBq@350KeV NEMA NU-2001). We think
that this system was still good only for brain study; how-
ever, it seemed to be old system in these days. It had no
CT system and lower energy resolution (23%) than LSO
or LYSO system (10–14%). State-of-the-art time-of-flight
PET/CT system is better for further analysis.
As for SPECT system, we used triple-head gamma cam-
era. Triple-head gamma camera with fan-beam collimator
had high spatial resolution with high sensitivity. Our re-
sults might be attributed to these features of triple-head
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gamma camera. As two-head gamma cameras are preva-
lent these days, the results might not be universal.
We did not correct scatter in SPECT study. New scat-
ter corrections without increasing noise were developed
[11]. With those scatter corrections, the correlation of
semiquantitative parameters of PET and SPECT might
become better without affecting visual diagnosis.
Conclusions
IMZ SPECT is as useful as FMZ PET for evaluating the
loss of neuronal integrity in patients presenting with
neurobehavioral disability after TBI.
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